First human test of new COVID-19 vaccine launches

NCT ID NCT04798027

Terminated ⭐️ VACCINE ⭐️ Sponsor: Sanofi Pasteur, a Sanofi Company Source: ClinicalTrials.gov ↗

Summary

This early-stage study tested a new mRNA vaccine designed to protect against COVID-19. It involved 182 healthy adults and aimed to see if the vaccine was safe and if it triggered a strong immune response against the virus. Researchers tracked participants for about a year to monitor side effects and measure antibody levels.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Investigational Site Number :0360001

Melbourne, Victoria, 3010, Australia
Investigational Site Number :0360002

Nedlands, Western Australia, 6009, Australia
Investigational Site Number :0360003

Morayfield, Queensland, 4506, Australia
Investigational Site Number :0360005

South Brisbane, Queensland, 4101, Australia
Investigational Site Number :0760001

Salvador, Estado de Bahia, 40415-006, Brazil
Investigational Site Number :0760003

Belo Horizonte, Minas Gerais, 30110-063, Brazil
Investigational Site Number :0760004

Campo Grande, Mato Grosso do Sul, 79070-900, Brazil
Investigational Site Number :3400001

San Pedro Sula, 21104, Honduras
Investigational Site Number :3400002

Barrio del Centro, 11101, Honduras
Investigational Site Number :8400001

Rochester, New York, 14609, United States
Investigational Site Number :8400002

Hollywood, Florida, 33024, United States
Investigational Site Number :8400003

Rolling Hills Estates, California, 90274, United States
Investigational Site Number :8400004

North Charleston, South Carolina, 29405, United States
Investigational Site Number :8400005

Salt Lake City, Utah, 84107, United States
Investigational Site Number :8400006

Miami, Florida, 33135, United States
Investigational Site Number :8400007

Kansas City, Missouri, 64114, United States
Investigational Site Number :8400008

Omaha, Nebraska, 68134, United States
Investigational Site Number :8400009

Houston, Texas, 77081, United States
Investigational Site Number :8400010

Philadelphia, Pennsylvania, 19104, United States
Investigational Site Number :8400015

Knoxville, Tennessee, 37920, United States
Investigational Site Number :8400017

Iowa City, Iowa, 52242, United States

Conditions

Explore the condition pages connected to this study.

COVID-19